Genprex

Tagged: Conferences

Genprex to Present at the 2021 Virtual Cell & Gene Meeting on the Mediterranean

Company overview to highlight novel gene therapies for cancer and diabetes

Read More

Genprex to Present at the Spring 2021 Oncology Investor Conference on March 29

Investor presentation to highlight novel gene therapies for cancer and diabetes

Read More

Genprex to Participate in Upcoming March Investor Conferences

Investor presentations to highlight novel gene therapies for cancer and diabetes

Read More

Genprex to Present at the Virtual Investor Conference Small and Microcap Showcase on February 4

Company to provide update on upcoming clinical trials for the treatment of non-small cell lung cancer and an overview of its diabetes gene therapy

Read More

Genprex to Participate in Panel at Life Sciences Summit on November 17

Thomas Gallagher, Senior VP of Intellectual Property and Licensing, to provide insight into IP best practices to early-stage companies

Read More

Genprex to Present at the Alliance for Regenerative Medicine’s Virtual Cell and Gene Meeting on the Mesa

The 2020 Cell and Gene Meeting on the Mesa will be delivered in a virtual format over the course of five days where attendees will be able to watch company presentations on-demand, in addition to two live-streaming panels each day.

Read More

Genprex to Present at The LD 500 Virtual Conference

Rodney Varner, Chairman and Chief Executive Officer of Genprex, will present virtually to an online audience on September 1, 2020 at 1:20 p.m. ET.

Read More